Joseph Kim, MD, MPH (Moderator)
Formerly: Vice President of Medical Affairs and Technology
Medical Communications Media, Inc.
Enoch Choi, MD
Palo Alto Medical Foundation
Palo Alto, CA
Michael J. Sevilla, MD
Family Practice Center of Salem
0.5 credit hour
0.5 prescribed credit Medium
Most primary care clinicians treat certain patients, particularly those with chronic conditions, who find it difficult to adhere to their medication regimens. Many of these providers are missing opportunities to help their patients improve adherence because they are not incorporating the latest in practice management and communication technologies. New and emerging capabilities and tools within electronic health records (EHRs), social media, and mobile technology can help providers improve patient adherence to their course of therapy.
This video roundtable discussion on social media is part of a series of activities that will provide information and resources to help primary care clinicians incorporate each of these evolving technologies into their practice, and to equip clinicians to apply these medical adherence strategies with their patients.
By accessing Sermo.com after the roundtable series, participants will have the opportunity to become engaged in social learning themselves, and to share experiences of both success and failure with colleagues, with continued dialogue with the program faculty. Program Developer/Facilitator
. Learning Objectives
Upon completion of this educational activity, the participant should be able to:
Outline the appropriate ways of communicating with colleagues and with patients on social media websites
Describe how social media can be used to communicate with patients about the importance of medication adherence.
The “Conflict of Interest Disclosure Policies” of Albert Einstein College of Medicine and NJAFP require that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.
The Albert Einstein College of Medicine (Einstein) and NJAFP also require that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.
Contributors whose COIs are irresolvable are not permitted to participate in Einstein and NJAFP CME activities.
Dr. Choi has no relevant financial conflicts to disclose.
Dr. Sevilla discloses that he has received honoraria as a speaker from EXL Pharma; Physician Interactive, and Swedish Medical Center.
Dr. Kim has no relevant financial conflicts to disclose.
Albert Einstein College of Medicine:
The staff of CCME of Albert Einstein College of Medicine have no conflicts of interests to report with commercial interests related directly or indirectly to this educational activity.
The staff of CCME of Albert Einstein College of Medicine have no disclosures to report with commercial interests other than the following:
Steven Jay Feld, or a member of his household own securities in:
Bioheart, Inc., Chelsea Therapeutics, Inc. and Pharmacopeia, Inc.
Ms. Barrett has no relevant financial conflicts to disclose.
Ms. Thier has no relevant financial conflicts to disclose.
Dr. Paczolt discloses that as Medical Director of a promotional medical communications company, her work received funding from Gilead Sciences, Novartis, Merck, and Ortho-Mcneil Janssen.
ACCME ACCREDITATION STATEMENT: Accreditation Council for Continuing Medical Education (ACCME) through joint sponsorship of Albert Einstein College of Medicine and Medical Communications Media, Inc. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
ACCME CREDIT DESIGNATION STATEMENT: Albert Einstein College of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in each activity.
This Enduring Material activity, Improving Medication Adherence: The Evolving Role of Technology, has been reviewed and is acceptable for up to 1.50 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins June 22, 2011. Term of approval is for one year from this date. Each webcast is approved for .50 Prescribed Credit may be claimed for one year from the date of each webcast. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support Statements
This activity was supported by a grant from Pfizer Inc.
Minimum Hardware/Software Requirements:
Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7. Or, Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers • High-speed internet connection • Internet Explorer 6.x or higher, Firefox 2.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser • Adobe Flash Player and/or an HTML5 capable browser may be required for video or audio playback • Adobe Acrobat Reader
Please turn off all pop-up blockers to assure access to the educational activity.
Click on the "Start program" icon at the bottom of this page.
The activity will take approximately 30 minutes to complete.
After the activity has finished, click on the "Post-test" button.
Instructions for completing and submitting the post-test and evaluation are provided on the post-test screen.
©2011, Albert Einstein College of Medicine, New Jersey Academy of Physicians and Medical Communications Media, Inc. All rights reserved. This publication is designed to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. None of the contents may be reproduced in any form without prior written permission from Albert Einstein College of Medicine, New Jersey Academy of Family Physicians and the publisher. The opinions expressed in this video roundtable are those of the speakers and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Albert Einstein College of Medicine, New Jersey Academy of Family Physicians, or Pfizer Inc. Any medications or other diagnostic or treatment procedures discussed by the program speakers should not be utilized by clinicians without evaluation of their patients’ conditions and possible contraindications or risks or without a review of any applicable manufacturer’s product information and comparison with the recommendations of other authorities.